Your browser does not fully support modern features. Please upgrade for a smoother experience.
Submitted Successfully!
Thank you for your contribution! You can also upload a video entry or images related to this topic. For video creation, please contact our Academic Video Service.
Version Summary Created by Modification Content Size Created at Operation
1 Rita Xu + 600 word(s) 600 2020-12-15 07:32:05

Video Upload Options

We provide professional Academic Video Service to translate complex research into visually appealing presentations. Would you like to try it?
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
Xu, R. Mucopolysaccharidosis Type VI. Encyclopedia. Available online: https://encyclopedia.pub/entry/4324 (accessed on 29 September 2026).
Xu R. Mucopolysaccharidosis Type VI. Encyclopedia. Available at: https://encyclopedia.pub/entry/4324. Accessed September 29, 2026.
Xu, Rita. "Mucopolysaccharidosis Type VI" Encyclopedia, https://encyclopedia.pub/entry/4324 (accessed September 29, 2026).
Xu, R. (2020, December 23). Mucopolysaccharidosis Type VI. In Encyclopedia. https://encyclopedia.pub/entry/4324
Xu, Rita. "Mucopolysaccharidosis Type VI." Encyclopedia. Web. 23 December, 2020.
Mucopolysaccharidosis Type VI
Edit

Mucopolysaccharidosis type VI (MPS VI), also known as Maroteaux-Lamy syndrome, is a progressive condition that causes many tissues and organs to enlarge and become inflamed or scarred. Skeletal abnormalities are also common in this condition. The rate at which symptoms worsen varies among affected individuals.

genetic conditions

References

  1. Azevedo AC, Schwartz IV, Kalakun L, Brustolin S, Burin MG, Beheregaray AP,Leistner S, Giugliani C, Rosa M, Barrios P, Marinho D, Esteves P, Valadares E,Boy R, Horovitz D, Mabe P, da Silva LC, de Souza IC, Ribeiro M, Martins AM,Palhares D, Kim CA, Giugliani R. Clinical and biochemical study of 28 patientswith mucopolysaccharidosis type VI. Clin Genet. 2004 Sep;66(3):208-13.
  2. Baehner F, Schmiedeskamp C, Krummenauer F, Miebach E, Bajbouj M, Whybra C,Kohlschütter A, Kampmann C, Beck M. Cumulative incidence rates of themucopolysaccharidoses in Germany. J Inherit Metab Dis. 2005;28(6):1011-7.
  3. Clarke LA. The mucopolysaccharidoses: a success of molecular medicine. Expert Rev Mol Med. 2008 Jan 18;10:e1. doi: 10.1017/S1462399408000550. Review.
  4. Garrido E, Chabás A, Coll MJ, Blanco M, Domínguez C, Grinberg D, Vilageliu L, Cormand B. Identification of the molecular defects in Spanish and Argentinianmucopolysaccharidosis VI (Maroteaux-Lamy syndrome) patients, including 9 novelmutations. Mol Genet Metab. 2007 Sep-Oct;92(1-2):122-30.
  5. Garrido E, Cormand B, Hopwood JJ, Chabás A, Grinberg D, Vilageliu L.Maroteaux-Lamy syndrome: functional characterization of pathogenic mutations and polymorphisms in the arylsulfatase B gene. Mol Genet Metab. 2008Jul;94(3):305-12. doi: 10.1016/j.ymgme.2008.02.012.
  6. Giugliani R, Harmatz P, Wraith JE. Management guidelines formucopolysaccharidosis VI. Pediatrics. 2007 Aug;120(2):405-18. Review.
  7. Karageorgos L, Brooks DA, Pollard A, Melville EL, Hein LK, Clements PR,Ketteridge D, Swiedler SJ, Beck M, Giugliani R, Harmatz P, Wraith JE, Guffon N,Leão Teles E, Sá Miranda MC, Hopwood JJ. Mutational analysis of 105mucopolysaccharidosis type VI patients. Hum Mutat. 2007 Sep;28(9):897-903.
  8. Lin HY, Lin SP, Chuang CK, Niu DM, Chen MR, Tsai FJ, Chao MC, Chiu PC, Lin SJ,Tsai LP, Hwu WL, Lin JL. Incidence of the mucopolysaccharidoses in Taiwan,1984-2004. Am J Med Genet A. 2009 May;149A(5):960-4. doi: 10.1002/ajmg.a.32781.
  9. Litjens T, Hopwood JJ. Mucopolysaccharidosis type VI: Structural and clinical implications of mutations in N-acetylgalactosamine-4-sulfatase. Hum Mutat. 2001Oct;18(4):282-95. Review.
  10. Nelson J, Crowhurst J, Carey B, Greed L. Incidence of themucopolysaccharidoses in Western Australia. Am J Med Genet A. 2003 Dec15;123A(3):310-3. Review.
  11. Tessitore A, Pirozzi M, Auricchio A. Abnormal autophagy, ubiquitination,inflammation and apoptosis are dependent upon lysosomal storage and are usefulbiomarkers of mucopolysaccharidosis VI. Pathogenetics. 2009 Jun 16;2(1):4. doi:10.1186/1755-8417-2-4.
More
Upload a video for this entry
Information
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register : Rita Xu
View Times: 632
Entry Collection: MedlinePlus
Revision: 1 time (View History)
Update Date: 23 Dec 2020
Notice
You are not a member of the advisory board for this topic. If you want to update advisory board member profile, please contact office@encyclopedia.pub.
OK
Confirm
Only members of the Encyclopedia advisory board for this topic are allowed to note entries. Would you like to become an advisory board member of the Encyclopedia?
Yes
No
${ textCharacter }/${ maxCharacter }
Submit
Cancel
There is no comment~
${ textCharacter }/${ maxCharacter }
Submit
Cancel
${ selectedItem.replyTextCharacter }/${ selectedItem.replyMaxCharacter }
Submit
Cancel
Confirm
Are you sure to Delete?
Yes No
Academic Video Service